Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Schned

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The American Journal of Pathology|February 13, 2001
Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoterW W Noll, D R Belloni, J L Rutter, et al.
The Journal of Urology|March 29, 2000
A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parametersT Schwaab, J A Heaney, A R Schned, et al.
Carcinogenesis|August 31, 2010
DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancerC S Wilhelm-Benartzi, D C Koestler, E A Houseman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neuT Schwaab, L D Lewis, B F Cole, et al.
Carcinogenesis|November 2, 2010
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysisL E Moore, D R Baris, J D Figueroa, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The American Journal of Pathology|February 13, 2001
Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoterW W Noll, D R Belloni, J L Rutter, et al.
The Journal of Urology|March 29, 2000
A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parametersT Schwaab, J A Heaney, A R Schned, et al.
Carcinogenesis|August 31, 2010
DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancerC S Wilhelm-Benartzi, D C Koestler, E A Houseman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neuT Schwaab, L D Lewis, B F Cole, et al.
Carcinogenesis|November 2, 2010
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysisL E Moore, D R Baris, J D Figueroa, et al.
Pageof 5